Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


Recommendation Rating







1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 48.64

Low: 43

High: 55.5

Total Analysts: 24

Company Profile

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s business segments include MedSurg, Rhythm and Neuro, and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Pelvic Health. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal (GI) and pulmonary conditions. Its Urology and Pelvic Health business develops and manufactures devices to treat various urological and pelvic conditions. The Rhythm and Neuro segment include Cardiac Rhythm Management (CRM) and Electrophysiology. Its CRM develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan